Skip to main content
915 TLDR
Health
1 read

FDA Denies Moderna's Application for New mRNA Influenza Vaccine

KTSM••The Associated Press
Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KTSM

Read Original

AI Summary

The FDA has made an unusual decision by rejecting Moderna's application for a new mRNA flu vaccine, a move that typically follows extensive discussions between the company and regulatory staff. This denial highlights the challenges vaccine developers face in gaining approval, especially for innovative technologies. The implications of this decision could affect public health strategies and vaccine availability during flu seasons. Stakeholders in the healthcare and pharmaceutical sectors will need to monitor further developments regarding this vaccine's future.

health public-health fda vaccine moderna

People & Organizations

FDAModerna

Related Articles

KVIA•Apr 14

Key Updates: Military Setbacks, Health Concerns, and Sports Controversies

Recent reports highlight significant issues affecting various sectors. The USS Gerald R. Ford, America's largest aircraft carrier, faces setbacks after a fire incident during its extended deployment, raising concerns about military readiness. Health experts warn that ultraprocessed foods are leading to alarming increases in health issues, with some individuals developing marbled flesh, a sign of serious conditions. In the sports world, the Enhanced Games are set to allow legal doping, attracting athletes with promises of substantial financial rewards. These developments underscore pressing health and ethical challenges in society.

Health
1 min read
KVIA•Apr 14

Estudio revela beneficios de medicamentos GLP-1 más allá de la pérdida de peso

Un nuevo estudio ha encontrado que los medicamentos GLP-1, como Wegovy y Zepbound, ofrecen beneficios significativos para la salud que no dependen de la pérdida de peso. Aunque entre el 10% y el 15% de los usuarios son considerados 'no respondedores' en términos de reducción de peso, estos fármacos pueden mejorar la salud cardiovascular y hepática. Wegovy ha sido aprobado para tratar la esteatohepatitis asociada a disfunción metabólica, que afecta al 6% de los adultos en EE. UU. Los investigadores sugieren que las aseguradoras deben reconsiderar sus criterios de cobertura, ya que los beneficios metabólicos podrían ser más amplios de lo que se pensaba anteriormente.

Health
1 min read
KVIA•Apr 14

Estudio revela que alimentos ultraprocesados afectan la salud muscular en El Paso

Un nuevo estudio destaca los efectos negativos de los alimentos ultraprocesados en la salud muscular, revelando que más del 50% de las calorías consumidas por adultos en EE. UU. provienen de estos productos. Investigadores de la Universidad de California encontraron que el consumo elevado de estos alimentos se asocia con un aumento de grasa intramuscular, lo que puede contribuir a problemas de salud como la osteoartritis de rodilla. Las resonancias magnéticas de 615 participantes mostraron que aquellos con dietas ricas en ultraprocesados presentaban una calidad muscular comprometida. Este hallazgo es preocupante, dado que la debilidad muscular puede aumentar el riesgo de complicaciones en la salud, especialmente en personas con obesidad. Se recomienda adoptar una dieta más saludable y realizar ejercicios de bajo impacto para mejorar la calidad muscular.

Health
1 min read
El Paso Matters•Apr 14

El Paso Mother Advocates for Faster FDA Approval of Rare Disease Treatments

Angelina Olivera, a resident of El Paso, expresses her frustration with the FDA's delays in approving treatments for rare diseases, particularly Duchenne muscular dystrophy, which affects her son Ryu. As Dr. Vinay Prasad departs from the FDA, Olivera highlights the urgent need for accelerated drug approvals, especially after the agency halted the only approved gene therapy for Duchenne following tragic patient deaths. Families of children with rare diseases are suffering as they wait for essential treatments that could prolong their lives. Olivera's advocacy at a Senate hearing has garnered bipartisan support, but she urges new FDA leadership to prioritize these urgent cases to prevent further decline in patients' health.

Health
1 min read